Alberto Contreras‐Sanz

503 total citations
19 papers, 332 citations indexed

About

Alberto Contreras‐Sanz is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Alberto Contreras‐Sanz has authored 19 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Alberto Contreras‐Sanz's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Molecular Sensors and Ion Detection (2 papers). Alberto Contreras‐Sanz is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Molecular Sensors and Ion Detection (2 papers). Alberto Contreras‐Sanz collaborates with scholars based in Canada, United Kingdom and Switzerland. Alberto Contreras‐Sanz's co-authors include Peter C. Black, Claire M. Peppiatt‐Wildman, Scott S. Wildman, Roland Seiler, Hardyal Gill, Kevin Taylor, James Malone‐Lee, Akshay Bhat, Toby S. Scott‐Ward and Akio Matsubara and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Alberto Contreras‐Sanz

19 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Contreras‐Sanz Canada 11 146 112 56 53 35 19 332
Ranxi Zhang China 11 241 1.7× 45 0.4× 12 0.2× 36 0.7× 56 1.6× 17 384
Maite Jiménez-Vidal Spain 9 230 1.6× 17 0.2× 122 2.2× 68 1.3× 37 1.1× 9 581
Jong Woo Kim South Korea 14 134 0.9× 41 0.4× 29 0.5× 67 1.3× 34 1.0× 41 624
Michael Haerter Germany 4 256 1.8× 12 0.1× 50 0.9× 41 0.8× 136 3.9× 8 471
Klaus Maier Italy 9 221 1.5× 176 1.6× 31 0.6× 28 0.5× 55 1.6× 11 434
Kenneth W. Batchelor United States 9 159 1.1× 29 0.3× 111 2.0× 53 1.0× 25 0.7× 12 442
Jing‐Ting Chiou Taiwan 12 247 1.7× 16 0.1× 40 0.7× 36 0.7× 53 1.5× 33 386
Sherri Smith United States 7 186 1.3× 27 0.2× 24 0.4× 48 0.9× 19 0.5× 18 329
Mitsufumi Endo Japan 8 137 0.9× 83 0.7× 52 0.9× 102 1.9× 34 1.0× 20 310
Weihao Chen China 9 146 1.0× 43 0.4× 70 1.3× 62 1.2× 66 1.9× 25 317

Countries citing papers authored by Alberto Contreras‐Sanz

Since Specialization
Citations

This map shows the geographic impact of Alberto Contreras‐Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Contreras‐Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Contreras‐Sanz more than expected).

Fields of papers citing papers by Alberto Contreras‐Sanz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Contreras‐Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Contreras‐Sanz. The network helps show where Alberto Contreras‐Sanz may publish in the future.

Co-authorship network of co-authors of Alberto Contreras‐Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Contreras‐Sanz. A scholar is included among the top collaborators of Alberto Contreras‐Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Contreras‐Sanz. Alberto Contreras‐Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Contreras‐Sanz, Alberto, Gian Luca Negri, Htoo Zarni Oo, et al.. (2025). Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy. Nature Communications. 16(1). 1240–1240. 3 indexed citations
2.
Zhang, Allen, Alberto Contreras‐Sanz, Martin Köbel, et al.. (2024). Learning generalizable AI models for multi-center histopathology image classification. npj Precision Oncology. 8(1). 151–151. 12 indexed citations
3.
Black, Peter C., et al.. (2023). A systematic review of nanocarriers for treatment of urologic cancers. Urologic Oncology Seminars and Original Investigations. 42(4). 75–101. 2 indexed citations
4.
Chou, Jonathan, Martin Sjöström, Emily A. Egusa, et al.. (2022). TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. European Urology Oncology. 5(6). 714–718. 56 indexed citations
5.
Gil-Jimenez, Alberto, Alberto Contreras‐Sanz, Daniël J. Vis, et al.. (2022). Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European Urology. 83(4). 313–317. 26 indexed citations
6.
Villamil, Carlos F., Ewan A. Gibb, Htoo Zarni Oo, et al.. (2022). Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(3). 397–403. 3 indexed citations
7.
Shiota, Masaki, Takashi Matsumoto, Mikako Yagi, et al.. (2022). Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine. Scientific Reports. 12(1). 8535–8535. 4 indexed citations
8.
Li, Henry, Chen Zhou, Wei Xiong, et al.. (2022). Classifying Pulmonary and Urinary High-grade Neuroendocrine Carcinoma by CK7 Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 30(6). 459–468. 2 indexed citations
9.
Kawai, Yoshihisa, Kenjiro Imada, Shusuke Akamatsu, et al.. (2020). Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer. Molecular Cancer Therapeutics. 19(10). 2210–2220. 12 indexed citations
10.
Contreras‐Sanz, Alberto, Kenichiro Ikeda, Gerald Bastian Schulz, et al.. (2020). FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(12). 904–905. 3 indexed citations
11.
Seiler, Roland, Alexander W. Wyatt, Alberto Contreras‐Sanz, et al.. (2018). Unravelling disparate roles of NOTCH in bladder cancer. Nature Reviews Urology. 15(6). 345–357. 45 indexed citations
12.
Dobranowski, Peter, Fuqiang Ban, Alberto Contreras‐Sanz, Artem Cherkasov, & Peter C. Black. (2017). Perspectives on the discovery of NOTCH2‐specific inhibitors. Chemical Biology & Drug Design. 91(3). 691–706. 7 indexed citations
13.
Contreras‐Sanz, Alberto, Morgan E. Roberts, Roland Seiler, & Peter C. Black. (2016). Recent progress with next‐generation biomarkers in muscle‐invasive bladder cancer. International Journal of Urology. 24(1). 7–15. 12 indexed citations
14.
Contreras‐Sanz, Alberto, Aswini Balachandran, Rajvinder Khasriya, et al.. (2016). Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria. American Journal of Physiology-Renal Physiology. 311(4). F805–F816. 18 indexed citations
15.
Kelley, Stephen P., Alberto Contreras‐Sanz, Mark Kelly, et al.. (2014). Urinary ATP and visualization of intracellular bacteria: a superior diagnostic marker for recurrent UTI in renal transplant recipients?. SpringerPlus. 3(1). 200–200. 7 indexed citations
16.
Contreras‐Sanz, Alberto, Toby S. Scott‐Ward, Hardyal Gill, et al.. (2012). Simultaneous quantification of 12 different nucleotides and nucleosides released from renal epithelium and in human urine samples using ion-pair reversed-phase HPLC. Purinergic Signalling. 8(4). 741–751. 51 indexed citations
17.
Szymańska, Ewa, Karla Frydenvang, Alberto Contreras‐Sanz, et al.. (2011). A New Phenylalanine Derivative Acts as an Antagonist at the AMPA Receptor GluA2 and Introduces Partial Domain Closure: Synthesis, Resolution, Pharmacology, and Crystal Structure. Journal of Medicinal Chemistry. 54(20). 7289–7298. 18 indexed citations
18.
19.
Wildman, Scott S., Michelle Boone, Claire M. Peppiatt‐Wildman, et al.. (2009). Nucleotides Downregulate Aquaporin 2 via Activation of Apical P2 Receptors. Journal of the American Society of Nephrology. 20(7). 1480–1490. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ranxi Zhang Breakdown of academic impact, for papers by Maite Jiménez-Vidal Breakdown of academic impact, for papers by Jong Woo Kim Breakdown of academic impact, for papers by Michael Haerter Breakdown of academic impact, for papers by Klaus Maier Breakdown of academic impact, for papers by Kenneth W. Batchelor Breakdown of academic impact, for papers by Jing‐Ting Chiou Breakdown of academic impact, for papers by Sherri Smith Breakdown of academic impact, for papers by Mitsufumi Endo Breakdown of academic impact, for papers by Weihao Chen
Rankless by CCL
2026